Articles About JNJ
-
October 17, 2012Johnson & Johnson Earnings Call Insights: Gross Margin, Pharma Performance
What investors need to know...
-
October 17, 2012Kroger Kicks Off Expansion Strategy and 3 Stocks Enjoying 52-Week Highs
See which companies are seeing their stock prices at annual highs right now...
-
October 16, 2012BofA Bolsters China Focus and 3 Dow Stocks Attract Investor Interest
These stocks are moving the Dow now...
-
October 16, 2012RBS-Santander Suit a Distinct Possibility and 3 Hot Stocks Seeing Action
Headlines you need to know this morning…
-
October 16, 2012Mid-Day Buzzers: Pandit Resigns from Citigroup, Coca-Cola Edges Lower
Analysis on highly active stocks for investors...
-
October 16, 2012
JPMorgan Chase Plans Bond Offering and 3 Dow Movers Seeing Action Today
The Dow is up 0.72 percent today and stands at 13,425. These stocks are moving the Dow now...
-
October 15, 2012Can Johnson & Johnson Beat Analysts’ Estimates?
When Johnson and Johnson reports third quarter earnings on Tuesday, the company is expected to report revenues of $16.9 billion...
-
October 15, 2012Johnson & Johnson Deemed Stable and 4 Stock Analyses to Watch
Here's what analysts had to say about these companies today...
-
October 14, 2012Here’s Why Eli Lilly Can’t Forget Alzheimer’s Treatments
Washington University at St. Louis announced on Wednesday that its Dominantly Inherited Alzheimer's Network Trials Unit will be conducting clinical trials of experimental Alzheimer’s treatments...
-
October 10, 2012Cramer: Sell WWE, Illumina and Buy Visa and These 2 Movers Today
It's always a good strategy to track transparency of pundits...
-
October 10, 2012Healthcare Business Recap: J&J’s New Manufacturing Process, NuPathe Cuts Workforce
Your Cheat Sheet to the top healthcare business news...
-
October 10, 2012Here’s How Eli Lilly Rescued its Alzheimer’s Drug
Shares of the Indianapolis-based drugmaker Eli Lilly topped $50 on Monday for the first time in more than four years due to positive clinical trial results...
-
October 09, 2012
Cramer: Sell Questcor, Novagold and Buy J&J and These 2 Performers Today
It's always a good strategy to track transparency of pundits...
-
October 09, 2012
Johnson & Johnson’s New Application and 2 Drug Stocks with Regulatory News Now
Your Cheat Sheet to important regulatory news for investors...
-
October 07, 2012Investors: Here’s a Glimpse into the Tough World of Pharmaceuticals
For pharmaceutical manufacturers Pfizer and Johnson & Johnson, business has been fraught with pitfalls, like revoked patents and large lawsuits, but for drug manufacturer Merck, the announcement of new clinical trial results have driven up share prices...
Wall St. Cheat Sheet has been featured in these fine media outlets:
